Found 193 results
Author Title Type [ Year(Asc)]
Filters: Author is Luiz E Bermudez  [Clear All Filters]
M. Petrofsky and Bermudez, L. E., CD4+ T cells but Not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route., Infection and immunity, vol. 73, no. 5, pp. 2621-7, 2005.
R. Roy MacGregor, Hafner, R., Wu, J. W., Murphy, R. L., Perlman, D. C., Bermudez, L. E., Inderlied, C. B., Picker, L. J., Wallis, R. S., Andersen, J. W., Mahon, L. F., Koletar, S. L., and Peterson, D. M., Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study., AIDS research and human retroviruses, vol. 21, no. 8, pp. 689-95, 2005.
D. Wagner, Maser, J., Lai, B., Cai, Z., Barry, C. E., Bentrup, K. Höner Zu, Russell, D. G., and Bermudez, L. E., Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system., Journal of immunology (Baltimore, Md. : 1950), vol. 174, no. 3, pp. 1491-500, 2005.
D. Wagner, Sangari, F. J., Parker, A., and Bermudez, L. E., fecB, a gene potentially involved in iron transport in Mycobacterium avium, is not induced within macrophages., FEMS microbiology letters, vol. 247, no. 2, pp. 185-91, 2005.
L. Danelishvili, Wu, M., Young, L. S., and Bermudez, L. E., Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria., Antimicrobial agents and chemotherapy, vol. 49, no. 9, pp. 3707-14, 2005.
E. Miltner, Daroogheh, K., Mehta, P. K., Cirillo, S. L. G., Cirillo, J. D., and Bermudez, L. E., Identification of Mycobacterium avium genes that affect invasion of the intestinal epithelium., Infection and immunity, vol. 73, no. 7, pp. 4214-21, 2005.
Y. Li, Miltner, E., Wu, M., Petrofsky, M., and Bermudez, L. E., A Mycobacterium avium PPE gene is associated with the ability of the bacterium to grow in macrophages and virulence in mice., Cellular microbiology, vol. 7, no. 4, pp. 539-48, 2005.
L. E. Bermudez and Yamazaki, Y., Effects of macrolides and ketolides on mycobacterial infections., Current pharmaceutical design, vol. 10, no. 26, pp. 3221-8, 2004.
L. Danelishvili, Poort, M. J., and Bermudez, L. E., Identification of Mycobacterium avium genes up-regulated in cultured macrophages and in mice., FEMS microbiology letters, vol. 239, no. 1, pp. 41-9, 2004.
L. E. Bermudez, Petrofsky, M., and Sangari, F., Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype., Cell biology international, vol. 28, no. 5, pp. 411-9, 2004.
O. Chacon, Bermudez, L. E., and Barletta, R. G., Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis., Annual review of microbiology, vol. 58, pp. 329-63, 2004.
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease., Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
G. Carter, Young, L. S., and Bermudez, L. E., A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation., Antimicrobial agents and chemotherapy, vol. 48, no. 12, pp. 4907-10, 2004.
R. B. Cope, Stang, B. V., Valentine, B. A., and Bermudez, L. E., Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease., Photodermatology, photoimmunology & photomedicine, vol. 20, no. 1, pp. 14-20, 2004.
G. Carter, Wu, M., Drummond, D. C., and Bermudez, L. E., Characterization of biofilm formation by clinical isolates of Mycobacterium avium., Journal of medical microbiology, vol. 52, no. Pt 9, pp. 747-52, 2003.
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease., The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
J. P. Bannantine, Huntley, J. F. J., Miltner, E., Stabel, J. R., and Bermudez, L. E., The Mycobacterium avium subsp. paratuberculosis 35 kDa protein plays a role in invasion of bovine epithelial cells., Microbiology (Reading, England), vol. 149, no. Pt 8, pp. 2061-9, 2003.
L. Danelishvili, McGarvey, J., Li, Y. -jun, and Bermudez, L. E., Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells., Cellular microbiology, vol. 5, no. 9, pp. 649-60, 2003.
L. Danelishvili and Bermudez, L. E., Role of type I cytokines in host defense against Mycobacterium avium infection., Current pharmaceutical design, vol. 9, no. 1, pp. 61-5, 2003.
L. E. Bermudez, Reynolds, R., Kolonoski, P., Aralar, P., Inderlied, C. B., and Young, L. S., Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice., Antimicrobial agents and chemotherapy, vol. 47, no. 8, pp. 2685-7, 2003.